We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
Elevating AAV Care: Expert Strategies for Optimal Patient Outcomes
May 24, 2024
13:45 - 14:45 CEST
Annette Bruchfeld, MD, PhD
Stephen McAdoo, MD
Andreas Kronbichler, MD
Identifying the Great Imitator – Demystifying the Systemic Features of IgG4-Related Disease
May 28, 2024
12:00 PM - 01:00 PM EDT
John H. Stone, MD, MPH
Emanuel Della Torre, MD, PhD
Yoh Zen, MD, PhD, FRCPath
Curbside Consult: Optimizing IgAN Management
Khalil El Karoui, MD
Federico Alberici, MD, PhD
Early Recognition and Diagnosis of Castleman Disease
Sanam Loghavi, MD
Razelle Kurzrock, MD, FACP
Understanding the Recent Advances in IgAN
Jürgen Floege, MD
Jonathan Barratt, PhD
Almost Like Being There: Updates in IgA Nephropathy From Kidney Week
Howard Trachtman, MD, FASN
Hiddo L. Heerspink, PhD
Exploring Developments in IgAN and FSGS
Richard Lafayette, MD, FACP
Taking the Patient-Centered Approach to Mycophenolate Risk Mitigation
Cara Dolin, MD
Jennifer Simpson
Diana Girnita, MD ,PhD
Incorporating Targeted Therapies in Treatment Planning for AAV
David Jayne, MD
Bernhard Hellmich, MD
What’s New About Gout? Rheumatology Perspective
Richard Johnson, MD
John K. Botson, MD, RPh
Treat or Refer: Who Is Responsible for Managing Gout?
Abdul Abdellatif, MD, FASN
What Are the Emerging Therapies for Managing Gout?
Can You Manage Patients With Uncontrolled Gout More Effectively?
Gout Beyond the Joints: What’s the Hidden Danger?
The Underestimated Consequences of Uncontrolled Gout: Renal and Cardiovascular Implications
Brittany Weber, MD, PhD
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education